US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,460.29

-31.8848-2.14%

Number of Gainers:3

Number of Losers:4

Number of Flat:- -

PE:- -

High:1,485.06

Open:1,483.83

Low:1,455.39

Close:1,492.17

Loading ...

Where Will Eli Lilly Be in 5 Years?

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stocks to Buy Now?

Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire

Positive Results From Tezspire® (Tezepelumab-Ekko) Phase 3 Waypoint Trial Highlight Rapid, Sustained Effect in Chronic Rhinosinusitis With Nasal Polyps

THOMSON REUTERS

POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

Pfizer (NYSE:PFE) Has A Pretty Healthy Balance Sheet

Simply Wall St.

Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note

Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025

AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

Why Pfizer Inc. (PFE) is the Best Vaccine Stock to Buy According to Hedge Funds?

Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

Pfizer quietly made some big DEI changes

Eli Lilly takes aim at weight-loss drug copies with new ad campaign

BRIEF-EMA's CHMP Adopts Indication Extension For Abrysvo To Include Adults From 18 Years

Eli Lilly Gets CHMP Backing of Jaypirca in Chronic Lymphocytic Leukemia

Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4599/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1460.2885,"timestamp":1741287264941,"preClose":1492.1732,"halted":0,"volume":31346331,"delay":0,"changeRate":-0.021368,"change":-31.884766,"pbRate":11.780703,"amount":2951307210.917016,"amplitude":0.019884,"prevYearClose":1305.0607,"fiveDayClose":1460.4895,"twentyDayClose":1394.0055,"turnoverRate":0.002969,"marketCap":1571263767328,"floatMarketCap":1459116058912,"peRate":41.703544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1485.0612,"amplitude":0.019884,"preClose":1492.1732,"low":1455.3911,"pbRate":"11.780703","latestPrice":1460.2885,"volume":31346331,"delay":0,"open":1483.8325,"prevYearClose":1305.0607,"prevWeekClose":1482.1702,"prevMonthClose":1482.1702,"prevQuarterClose":1305.0607,"fiveDayClose":1460.4895,"twentyDayClose":1394.0055,"sixtyDayClose":1438.0239,"secType":"PLATE","market":"US","turnoverRate":0.002969,"peRate":41.703544,"marketCap":1571263767328,"floatMarketCap":1459116058912,"timestamp":1741287264941,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":3,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:16,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516542866","title":"Where Will Eli Lilly Be in 5 Years?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516542866","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516542866?lang=en_us&edition=fundamental","pubTime":"2025-03-03 03:39","pubTimestamp":1740944340,"startTime":"0","endTime":"0","summary":"Eli Lilly is set to keep growing its revenue at a strong pace in the next five years.It's hard to argue with the kinds of results Eli Lilly  has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares leaving the broader market in the dust.Some might argue that it's too late for investors to get in on Eli Lilly, while others could feel that its work in the diabetes and obesity markets still makes it an attractive long-term option. Which side is right?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/02/where-will-eli-lilly-be-in-5-years/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0061475181.USD","LU1280957306.USD","GB00BDT5M118.USD","BK4007","LU0708995401.HKD","SG9999015952.SGD","SG9999017495.SGD","LU1267930730.SGD","LU2237443465.HKD","LLY","LU0097036916.USD","BK4599","LU1804176565.USD","LU0289739699.SGD","LU1551013342.USD","LU1291159041.SGD","LU1868837300.USD","LU0640476718.USD","SG9999018865.SGD","LU1127390331.HKD","LU0820561818.USD","LU1093756168.USD","LU1868836591.USD","SGXZ31699556.SGD","LU1989771016.USD","SG9999001176.SGD","SG9999018857.SGD","LU2491050071.SGD","LU1983299246.USD","IE00BJT1NW94.SGD","LU0417517546.SGD","IE00B1BXHZ80.USD","BK4516","SG9999015986.USD","LU0122379950.USD","LU0114720955.EUR","LU1548497426.USD","LU1035775433.USD","SG9999013999.USD","LU2461242641.AUD","IE00B2B36J28.USD","LU2602419157.SGD","LU2361044949.HKD","LU2360106947.USD","LU2106854487.HKD","LU2324357040.USD","LU0006306889.USD","LU0943347566.SGD","LU1720051017.SGD","IE00B4R5TH58.HKD"],"gpt_icon":1},{"id":"2516404545","title":"Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stocks to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516404545","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516404545?lang=en_us&edition=fundamental","pubTime":"2025-03-03 01:16","pubTimestamp":1740935800,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now.In this article, we are going to take a look at where Supernus Pharmaceuticals, Inc.  stands against the other small cap pharma stocks.Impact of US Tariffs and Obesity Drug Performance on the Pharmaceutical Industry. Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics of the pharmaceutical industry. According to her, the industry might not perform poorly at least in the first half of this year. The effectiveness of obesity medications is still up for debate, though, as leading companies in the field have shown inconsistent results.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/supernus-pharmaceuticals-inc-supn-best-171640328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","LU0823416689.USD",".IXIC","LU0471298777.SGD","SUPN","IE00BJT1NW94.SGD","ABVC","USJW.SI","LU0256863902.USD","LU2264538146.SGD","LU1064131342.USD","LU1712237335.SGD","LU0114720955.EUR","IE00B1BXHZ80.USD","QLD","LU0058720904.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","SQQQ","LU0385154629.USD","TSYW.SI","LU2237443549.SGD","TQQQ","LU0882574055.USD","LU2491049909.HKD","LU0006306889.USD","LU2063271972.USD","NQmain","BK4599","LU0106261372.USD","BK4516","LU0320765059.SGD","SGXZ31699556.SGD","PSQ","LU0061475181.USD","LU1280957306.USD","USAW.SI","LU0820561909.HKD","LU1868836757.USD","LLY","SG9999014898.SGD","LU0354030511.USD","LU0708995401.HKD","LU1974910355.USD","LU1267930730.SGD","NVIW.SI","LU2237443465.HKD","QID","LU2237443978.SGD"],"gpt_icon":1},{"id":"2516517473","title":"Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire","url":"https://stock-news.laohu8.com/highlight/detail?id=2516517473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516517473?lang=en_us&edition=fundamental","pubTime":"2025-03-02 22:10","pubTimestamp":1740924616,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE significantly...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-results-from-phase-3-waypoint-trial-on-tezspire?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-results-from-phase-3-waypoint-trial-on-tezspire?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE00BJJMRZ35.SGD","BK4139","LU0320765992.SGD","BK4533","BK4566","LU0058720904.USD","LU2462157665.USD","LU2112291526.USD","LU1829250122.USD","AMGN","BK4599","LU1023059063.AUD","BK4585","LU2236285917.USD","BK4568","SG9999001440.SGD","LU1571399168.USD","IE0002141913.USD","LU0122379950.USD","LU0289739699.SGD","IE00B2B36J28.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","BK4534","IE00B4R5TH58.HKD","LU2242646821.SGD","LU2417539215.USD","LU0868494617.USD","AZN","LU2242652126.USD","LU2456880835.USD","BK4007","LU1061106388.HKD","BK4581","LU1983299246.USD","IE00BJT1NW94.SGD","BK4588","LU0109394709.USD"],"gpt_icon":0},{"id":"2516564683","title":"Positive Results From Tezspire® (Tezepelumab-Ekko) Phase 3 Waypoint Trial Highlight Rapid, Sustained Effect in Chronic Rhinosinusitis With Nasal Polyps","url":"https://stock-news.laohu8.com/highlight/detail?id=2516564683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516564683?lang=en_us&edition=fundamental","pubTime":"2025-03-02 06:30","pubTimestamp":1740868224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250301:nTUABPTQMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJT1NW94.SGD","BK4534","BK4139","LU2242646821.SGD","LU2112291526.USD","LU0058720904.USD","BK4581","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1057294990.SGD","LU2242652126.USD","AMGN","LU0889565916.HKD","IE00BFTCPJ56.SGD","BK4599","BK4533","LU1983299246.USD","BK4588","BK4566","LU1061106388.HKD","IE00B2B36J28.USD","LU0320765992.SGD","LU0289739699.SGD","LU0109394709.USD","IE0002141913.USD","SG9999001440.SGD","IE0009355771.USD","LU0122379950.USD","LU0868494617.USD","LU1571399168.USD","BK4585","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2516564150","title":"POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2516564150","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516564150?lang=en_us&edition=fundamental","pubTime":"2025-03-02 06:30","pubTimestamp":1740868200,"startTime":"0","endTime":"0","summary":"Significantly Reduced Nasal Congestion, Polyp Size and Nearly Eliminated Need for Surgery. Data Published in NEJM and Presented at AAAAI/WAO 2025. THOUSAND OAKS, Calif., March 1, 2025 /PRNewswire/ -- Amgen  and AstraZeneca today announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE significantly reduced nasal polyp severity, the need for surgery and systemic corticosteroid use in patients with chronic rhinosinusitis with nasal polyps  compared to placebo.1,2 The data were published today in the New England Journal of Medicineand were highlighted as a late-breaking oral presentation during the American Academy of Allergy Asthma & Immunology /World Allergy Organization  Joint Congress in San Diego.1,2. \"Chronic rhinosinusitis with nasal polyps is a recurrent condition often requiring repeat courses of systemic corticosteroids, even for patients on currently available biologics, and can require repeat surgeries,\" said Jay Bradner, M.D., executi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/positive-results-tezspire-tezepelumab-ekko-223000167.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/positive-results-tezspire-tezepelumab-ekko-223000167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0532188223.SGD","IE00BJT1NW94.SGD","SG9999014484.SGD","BK4534","TSLP","SG9999002414.USD","LU2242646821.SGD","LU0516422952.EUR","LU0048573645.USD","LU0737861269.HKD","BK4581","IE00BJJMRZ35.SGD","FL","BK4503","LU0261945553.USD","LU1023059063.AUD","SG9999002620.SGD","LU2242652126.USD","AMGN","LU0889565916.HKD","LU2045819591.USD","SG9999004360.SGD","TSS","SGXZ58947870.SGD","SG9999013478.USD","IE0034224299.USD","LU1242518857.USD","BK4599","LU0572940350.SGD","SG9999006266.SGD","LU1983299246.USD","LU0251143029.SGD","SG9999013486.USD","BK4588","LU0210637038.USD","LU1061106388.HKD","LU1242518931.SGD","SG9999013460.SGD","LU0516423091.SGD","LU0320765992.SGD","LU0289739699.SGD","IE0002141913.USD","LU0572939691.SGD","SG9999001440.SGD","BK4535","LU0264606111.USD","SG9999002406.SGD","BK4585","IE00B4R5TH58.HKD"],"gpt_icon":1},{"id":"2516552661","title":"Pfizer (NYSE:PFE) Has A Pretty Healthy Balance Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552661","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516552661?lang=en_us&edition=fundamental","pubTime":"2025-03-01 22:00","pubTimestamp":1740837617,"startTime":"0","endTime":"0","summary":"Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We can see that Pfizer Inc.  does use debt in its business. But should shareholders be worried about its use of debt?Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. However, a more usual  situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-nyse-pfe-pretty-healthy-140017905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","PFE","LU1057294990.SGD","IE000M9KFDE8.USD","LU0321505439.SGD","LU1023059063.AUD","SGXZ57979304.SGD","BK4585","BK4533","LU0170899867.USD","LU0868494617.USD","LU0122379950.USD","IE0002270589.USD","LU0306806265.USD","IE00B19Z3B42.SGD","SG9999013999.USD","BK4581","LU0225771236.USD","LU1066053197.SGD","LU0058720904.USD","SG9999002232.USD","LU1894683264.USD","LU0289739699.SGD","BK4568","LU0985481810.HKD","SG9999001176.USD","IE00BBT3K403.USD","LU1066051498.USD","BK4592","BK4588","IE00BLSP4452.SGD","SG9999002224.SGD","EBIT","BK4534","SG9999003800.SGD","LU0306807586.USD","BK4599","NYSE","LU0234572021.USD","LU0456855351.SGD","LU0321505868.SGD","SG9999011175.SGD","LU1883839398.USD","IE00BLSP4239.USD","LU0225284248.USD","SG9999001176.SGD","LU1894683348.USD","IE00B19Z3581.USD","BK4550"],"gpt_icon":1},{"id":"2516589974","title":"Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note","url":"https://stock-news.laohu8.com/highlight/detail?id=2516589974","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516589974?lang=en_us&edition=fundamental","pubTime":"2025-03-01 06:45","pubTimestamp":1740782719,"startTime":"0","endTime":"0","summary":"In the latest trading session, Viking Therapeutics, Inc.  closed at $28.87, marking a +0.7% move from the previous day. This move lagged the S&P 500's daily gain of 1.59%. Meanwhile, the Dow experienced a rise of 1.39%, and the technology-dominated Nasdaq saw an increase of 1.63%.Coming into today, shares of the company had lost 14.9% in the past month. In that same time, the Medical sector lost 0.63%, while the S&P 500 lost 2.42%.Analysts and investors alike will be keeping a close eye on the performance of Viking Therapeutics, Inc. in its upcoming earnings disclosure. In that report, analysts expect Viking Therapeutics, Inc. to post earnings of -$0.34 per share. This would mark a year-over-year decline of 30.77%.Investors might also notice recent changes to analyst estimates for Viking Therapeutics, Inc. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-inc-vktx-ascends-224519390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","BK4588","VKTX","BK4585","BK4139"],"gpt_icon":1},{"id":"2516466300","title":"Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516466300","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516466300?lang=en_us&edition=fundamental","pubTime":"2025-03-01 06:37","pubTimestamp":1740782264,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street.In this article, we are going to take a look at where Amgen Inc.  stands against the other AI stocks.In a recent discussion at CNBC's 'Squawk on the Street', NYU professor and AI expert, Gary Marcus shared his perspective on the limitations of current AI models, the hurdles in enterprise adoption, and the financial sustainability of major AI companies. His insights raise important questions about the future of AI and whether it can truly deliver on its ambitious promises.AI’s Future Faces Hurdles in Reliability, Costs, and Enterprise Use. At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-inc-amgn-invests-200m-223744169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","IE00B2B36J28.USD","TSYW.SI","SQQQ","MNQmain","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4533","IE00BFTCPJ56.SGD","NVIW.SI","LU1061106388.HKD","QLD","BK4599","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","TQQQ","LU1571399168.USD","QID","USJW.SI","LU1057294990.SGD","USAW.SI","LU0109394709.USD","IE0002141913.USD","LU0320765992.SGD","LU0889565916.HKD","LU1023059063.AUD","LU0122379950.USD","BK4139","AMGN","BK4585","LU0058720904.USD","BK4588","IE0009355771.USD","NQmain","LU0289739699.SGD","LU0868494617.USD","PSQ","LU2112291526.USD","BK4566","LU2242652126.USD","LU1983299246.USD",".IXIC","SG9999001440.SGD","BK4581"],"gpt_icon":1},{"id":"2516830105","title":"AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE","url":"https://stock-news.laohu8.com/highlight/detail?id=2516830105","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516830105?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:01","pubTimestamp":1740776460,"startTime":"0","endTime":"0","summary":"THOUSAND OAKS, Calif., Feb. 28, 2025 /PRNewswire/ --Amgen  will present at the 45th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Wednesday, March 5, 2025. Jay Bradner, executive vice president of Research and Development at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.For more information, visit Amgen.comand follow us on X, LinkedIn, Instagram,YouTubeand Threads.CONTA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/amgen-present-45th-annual-td-210100755.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-present-45th-annual-td-210100755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1057294990.SGD","IE00BFTCPJ56.SGD","COWN","BK4139","LU1571399168.USD","LU0058720904.USD","IE0002141913.USD","LU1061106388.HKD","LU2242646821.SGD","AMGN","BK4534","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","CARE","LU0889565916.HKD","LU1023059063.AUD","IE00B2B36J28.USD","BK4211","BK4533","IE0009355771.USD","LU2242652126.USD","BK4207","BK4581","TD","LU2112291526.USD","LU0868494617.USD","LU0320765992.SGD","LU0122379950.USD","BK4599","LU0109394709.USD","BK4585","IE00B4R5TH58.HKD","BK4566","BK4127","LU1983299246.USD","BK4588","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2516720943","title":"Why Pfizer Inc. (PFE) is the Best Vaccine Stock to Buy According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516720943","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516720943?lang=en_us&edition=fundamental","pubTime":"2025-03-01 01:31","pubTimestamp":1740763919,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc.  stands against the other best vaccine store stocks to buy now.What Will Trump’s Tariffs Mean for the Pharma Industry?On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of their month-long delay on their implementation. When asked about the postponed tariffs at a White House press conference, President Trump said:. “The tariffs are going forward on time, on schedule.”He claimed that foreign nations have been taking advantage of the US in “just about everything,” reiterating his plans to impose “reciprocal tariffs.”“So the tariffs will go forward, yes, and we’re going to make up a lot of territory,” Trump said.READ ALSO:10 Best Performing Pharma Stocks So Far in 2025and10 Oversold Pharma Stocks to Buy According to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-pfizer-inc-pfe-best-173159236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU1894683348.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0225771236.USD","SG9999003800.SGD","BK4585","BK4599","LU0321505868.SGD","SG9999001176.SGD","SG9999002224.SGD","LU0170899867.USD","LU0306806265.USD","LU1057294990.SGD","LU1894683264.USD","SG9999013999.USD","BK4592","LU0985481810.HKD","IE0002270589.USD","LU1066053197.SGD","LU1883839398.USD","LU0122379950.USD","LU0225284248.USD","IE00BLSP4452.SGD","LU1066051498.USD","IE00BBT3K403.USD","BK4581","BK4534","LU0868494617.USD","BK4588","LU0058720904.USD","BK4550","IE00B19Z3581.USD","LU0306807586.USD","LU0456855351.SGD","IE00BLSP4239.USD","LU0234572021.USD","LU0321505439.SGD","LU0289739699.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","SG9999002232.USD","SG9999011175.SGD","BK4533","PFE"],"gpt_icon":1},{"id":"2516810377","title":"Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516810377","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516810377?lang=en_us&edition=fundamental","pubTime":"2025-03-01 01:30","pubTimestamp":1740763822,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Worst Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going to take a look at where Viking Therapeutics, Inc.  stands against other worst performing mid cap stocks to buy according to analysts.Hall highlighted that interest rates still play a crucial role in market dynamics. Bank of America’s economists expect the Fed to maintain its current stance without further cuts, which could pose refinancing risks for small caps. Mid-caps, on the other hand, have better balance sheets and fundamental trends, which positions them more favorably. Despite the optimism around economic policies and potential deregulation, Hall noted that small caps face a high bar for investor confidence after a decade of underperformance. Historically, small caps are due for an outperformance cycle, and relative valuations suggest they could offer the best price returns over the next decade. However, for this year, investors are cautious about reente","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-inc-vktx-worst-173022728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ",".IXIC","NQmain","TSYW.SI","BK4585","MNQmain","NVIW.SI","BK4588","SQQQ","BK4139","USAW.SI","USJW.SI","PSQ","QLD","QID","VKTX","BK4599"],"gpt_icon":1},{"id":"2516637209","title":"Pfizer quietly made some big DEI changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637209","media":"Quartz","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516637209?lang=en_us&edition=fundamental","pubTime":"2025-03-01 00:29","pubTimestamp":1740760140,"startTime":"0","endTime":"0","summary":"Pfizer logo is seen on Pfizer World Headquarters in Manhattan, New York, United States of America, on July 6th, 2024. - Image: NurPhoto / Contributor . Pfizer  made some major changes to its diversity, equity, and inclusion  webpage on Thursday, joining other major American corporations that have recently aligned themselves closer with the Trump administration.Other sections of the webpage underwent similar changes. A section previously titled “Diversity in Our Global Supply” has been renamed “Inclusive Supplier Strategy.” The paragraph under this heading now states, “All areas of our business groups are dedicated to finding and selecting the best suppliers,” replacing the previous language that emphasized advancing DEI.Pfizer did not immediately respond to a request for comment from Quartz. However, a company spokesperson told STAT News, which first reported the changes, “We constantly update and evolve the content and design of our website to reflect our current programs, initiatives","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-quietly-made-big-dei-162900503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU0096364046.USD","LU0417517546.SGD","IE00BJLML261.HKD","JNJ","LU0094547139.USD","LU1323610961.USD","BK4599","SG9999002224.SGD","LU1057294990.SGD","LU1430594728.SGD","IE00BVYPNV92.GBP","LU2491050154.USD","LU2242652126.USD","LU0109391861.USD","LU1066053197.SGD","LU1883839398.USD","PFE","LU0238689110.USD","LU0882574055.USD","LU1670710661.SGD","LU0471298694.HKD","BIIB","SGXZ81514606.USD","IE00BLSP4452.SGD","LU1066051498.USD","LU0868494617.USD","BK4581","DEI","LU1093756168.USD","LU2361045086.USD","LU2265009873.SGD","LU2129689514.USD","SG9999014898.SGD","LU0203345920.USD","BMY","LU0061475181.USD","LU1868836757.USD","LU0306807586.USD","IE00BVYPNW00.USD","LU1712237335.SGD","LU2133065610.SGD","LU0289739699.SGD","BK4223","LU1674673691.USD","SG9999001440.SGD","BK4504","BK4532","SG9999018857.SGD"],"gpt_icon":1},{"id":"2514778378","title":"Eli Lilly takes aim at weight-loss drug copies with new ad campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2514778378","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514778378?lang=en_us&edition=fundamental","pubTime":"2025-02-28 23:00","pubTimestamp":1740754800,"startTime":"0","endTime":"0","summary":"Eli Lilly takes aim at weight-loss drug copies with new ad campaignFeb 28 (Reuters) - Eli Lilly LLY.N launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PI21C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","SG9999015952.SGD","SG9999001176.USD","LU0006306889.USD","LU0203202063.USD","LU1548497426.USD","IE0002141913.USD","LU1917777945.USD","IE00BJLML261.HKD","LU0943347566.SGD","SG9999013999.USD","LU0640476718.USD","IE00B1BXHZ80.USD","LU1291159041.SGD","IE0004445239.USD","IE00BK4W5L77.USD","LU2211815571.USD","LU0456855351.SGD","IE00BFTCPJ56.SGD","SGXZ99366536.SGD","LU1814569148.SGD","LU0820561818.USD","LU1868837300.USD","LU0109391861.USD","LU0417517546.SGD","LU0058720904.USD","SG9999014880.SGD","SG9999001176.SGD","BK4007","LU0708995401.HKD","LU2360106947.USD","LU2361044865.SGD","SG9999018857.SGD","LU1988902786.USD","LLY","SG9999014906.USD","IE00BK4W5M84.HKD","SGXZ31699556.SGD","BK4588","GB00BDT5M118.USD","LU1983299246.USD","LU2237443895.HKD","LU2237443978.SGD","IE00B4R5TH58.HKD","LU0471298694.HKD","LU1804176565.USD","LU2237443465.HKD","LU2491049909.HKD","BK4599"],"gpt_icon":1},{"id":"2514205263","title":"BRIEF-EMA's CHMP Adopts Indication Extension For Abrysvo To Include Adults From 18 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2514205263","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514205263?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:36","pubTimestamp":1740753379,"startTime":"0","endTime":"0","summary":"BRIEF-EMA's CHMP Adopts Indication Extension For Abrysvo To Include Adults From 18 YearsFeb 28  - EMA's CHMP:CHMP ADOPTED EXTENSION TO EXISTING INDICATION TO EXTEND USE OF ABRYSVO TO ADULTS FROM 18 YEARS OF AGESource text: [ID:]Further company coverage: PFE.N ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","BK4592","LU0170899867.USD","LU0321505439.SGD","LU0456855351.SGD","PFE","IE00B19Z3B42.SGD","BK4534","IE0002270589.USD","LU0321505868.SGD","LU0306806265.USD","BK4533","SG9999001176.SGD","IE00BBT3K403.USD","BK4581","BK4599","BK4007","SG9999002232.USD","SG9999011175.SGD","BK4550","LU0225771236.USD","LU0234572021.USD","SG9999001176.USD","LU1883839398.USD","LU1057294990.SGD","LU0225284248.USD","LU0985481810.HKD","IE00B19Z3581.USD","SG9999013999.USD","SG9999002224.SGD","LU1023059063.AUD","LU0122379950.USD","LU1066051498.USD","BK4585","LU0058720904.USD","BK4588","SGXZ57979304.SGD","IE00BLSP4452.SGD","BK4568","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683264.USD","LU1066053197.SGD","IE00BLSP4239.USD","IE000M9KFDE8.USD","LU0306807586.USD"],"gpt_icon":0},{"id":"2514732264","title":"Eli Lilly Gets CHMP Backing of Jaypirca in Chronic Lymphocytic Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2514732264","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514732264?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:59","pubTimestamp":1740751140,"startTime":"0","endTime":"0","summary":"Eli Lilly said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its Jaypirca cancer drug in certain patients with chronic lymphocytic leukemia.Eli Lilly on Friday said the recommendation covers Jaypirca for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia who have been previously treated with a Bruton's tyrosine kinase inhibitor.The Indianapolis drugmaker said the European Commission, which generally follows the CHMP's advice, is expected to make a final decision in the next one to two months.Eli Lilly previously won conditional European approval for Jaypirca in adults with relapsed or refractory mantle cell lymphoma who have been previously treated with a BTK inhibitor.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999018857.SGD","LU0456855351.SGD","SG9999018865.SGD","SG9999001176.SGD","LU1868837300.USD","SG9999015945.SGD","LU1623119135.USD","LU0417517546.SGD","LU1035775433.USD","LU2237443622.USD","IE0002141913.USD","LU1720051017.SGD","BK4585","LU1061106388.HKD","SG9999014906.USD","LU1989771016.USD","SG9999013999.USD","BK4534","LU0096364046.USD","LU0238689110.USD","LU2361045086.USD","LU2264538146.SGD","LU2324357040.USD","LU1983299246.USD","LU2237443382.USD","LU1974910355.USD","LU0882574139.USD","LU2106854487.HKD","LU2602419157.SGD","LU1917777945.USD","LU1093756325.SGD","LU0354030438.USD","LU1868836757.USD","LU0708995401.HKD","LU2361044949.HKD","LU0672654240.SGD","SGXZ81514606.USD","LU0256863902.USD","LU0203202063.USD","LU1023059063.AUD","CHMP","LLY","SGXZ51526630.SGD","SG9999015986.USD","LU0079474960.USD","LU0466842654.USD","LU0106261372.USD","BK4599","IE00BK4W5M84.HKD","LU2089984988.USD"],"gpt_icon":1},{"id":"2514375462","title":"Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2514375462","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514375462?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:30","pubTimestamp":1740749453,"startTime":"0","endTime":"0","summary":"Hims & Hers Health put out a jaw dropping commercial. Now, Hims stock is just dropping, as its semaglutide business faces a setback.","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2025/02/TECH1_himshers_022825-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2025/02/TECH1_himshers_022825-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/hims-stock-hims-hers-health-semaglutide-shortage/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1868837136.USD","LU0640476718.USD","SG9999014914.USD","LU1291159041.SGD","LU0820561909.HKD","LU1548497426.USD","LU2461242641.AUD","IE00BJT1NW94.SGD","LU0354030511.USD","LU1917777945.USD","LU2089984988.USD","SG9999001176.SGD","SG9999014906.USD","LU0006306889.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU1814569148.SGD","SG9999018857.SGD","LU0471298694.HKD","LLY","SG9999017495.SGD","LU0203201768.USD","LU0094547139.USD","IE00BZ1G4Q59.USD","LU1974910355.USD","LU0238689110.USD","LU1064131342.USD","BK4534","LU1988902786.USD","SG9999015986.USD","HIMS","LU2602419157.SGD","NVO","LU0058720904.USD","NVO.AU","BK4516","LU0079474960.USD","LU2265009873.SGD","SGXZ57979304.SGD","BK4599","LU2361045086.USD","BK4007","IE00BJLML261.HKD","IE00BKVL7J92.USD","LU0466842654.USD","IE00BK4W5L77.USD","LU0096364046.USD","LU0320765059.SGD","LU0106261372.USD","LU1804176565.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":15,"pageCount":6,"totalSize":234}]}}